The 2026-2031 masterplan was approved at a meeting of the Emirates Genome Council. It moves the national programme from collecting genomic data to using that data in clinical care, early prevention and precision medicine, The National reported. The programme now has one million participants.
The plan has four initiatives. It extends the Emirati Genome Programme to all Emirati citizens and gives personalised genomic reports to 900,000 participants through the Tamm platform from December 2026. It also expands genetic screening of newborns to the whole country and strengthens the Trusted Research Environment for local and international research. Mansoor Al Mansoori, chairman of the Abu Dhabi Department of Health, said the plan sets new criteria for clinical genomics at community level.
Read the full report
The National — insurance ↗This is an original summary of the linked report, selected by our GCC market monitor. Facts are attributed to the publication.
